About Pisgah Labs
Pisgah Labs is a company based in Brevard (United States) founded in 1979 was acquired by Ipca Laboratories in January 2018. Pisgah Labs operates in a competitive market with competitors including Almac Group, Asymchem, Seqens, Aurobindo Pharma and Aptuit, among others.
- Headquarter Brevard, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
$50 K (USD), Grant
Jul 25, 2022
- Investors
-
Employee Count
Employee Count
-
Acquired by
Ipca Laboratories
(Jan 17, 2018)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Pisgah Labs
- Total Funding Total Funding
- Total Rounds 1
- Last Round Grant — $50,000
-
First Round
First Round
(25 Jul 2022)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2022 | Amount | Grant - Pisgah Labs | Valuation |
investors |
Investors in Pisgah Labs
Pisgah Labs has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include North Carolina Department of Commerce and Ipca Laboratories.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Provider of variety of services for connecting businesses with the talent, infrastructure and incentives
|
Founded Year | Domain | Location | |
|
Ipca Laboratories is engaged in pharmaceutical manufacturing and distribution.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Pisgah Labs
Financial Statements - Pisgah Labs
Pisgah Labs Comparisons
Competitors of Pisgah Labs
Pisgah Labs operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Almac Group, Asymchem, Seqens, Aurobindo Pharma and Aptuit, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Integrated CDMO services for biopharma R&D and manufacturing are offered.
|
|
| domain | founded_year | HQ Location |
APIs and peptides are developed and manufactured by Asymchem.
|
|
| domain | founded_year | HQ Location |
Contract manufacturing services for small molecules and peptides are provided.
|
|
| domain | founded_year | HQ Location |
Generic biocatalytic solutions are provided for pharmaceutical applications.
|
|
| domain | founded_year | HQ Location |
Contract research and development services for small molecules are offered.
|
|
| domain | founded_year | HQ Location |
APIs manufacturing and formulation services are provided in therapeutic segments.
|
Frequently Asked Questions about Pisgah Labs
Pisgah Labs was founded in 1979 and raised its 1st funding round 43 years after it was founded.
Pisgah Labs is headquartered in Brevard, United States. It is registered at Brevard, North Carolina, United States.
Founded in 1979 and based in Brevard, United States, Pisgah Labs operates in the pharmaceutical sector as a contract manufacturing organization. Services encompass production of various dosage forms across therapeutic categories, API manufacturing, custom formulations with modified release properties, aseptic processing, and microbiological testing. Expertise is applied to drug substance modifications, supporting co-development of oral and injectable ANDAs, with 10 patent applications filed to date.
Pisgah Labs's top competitors include Concord Biotech, Almac Group and Indoco Remedies.
Pisgah Labs has 2 investors. Key investors include North Carolina Department of Commerce, and Ipca Laboratories.